KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV)
Also known as KLOW Stack, Quad Healing Blend
KLOW adds KPV, a tripeptide fragment derived from alpha-melanocyte-stimulating hormone, to the GLOW Blend's combination of BPC-157, TB-500, and GHK-Cu. KPV is studied in preclinical models mainly for anti-inflammatory activity in gut-related and dermatological contexts, reportedly without the pigmentation effects associated with full melanocortin-receptor activation. As the newest and most complex of the commonly referenced healing blends, KLOW has the least combined research behind it, with most information originating from informal research communities rather than published studies of the four-peptide combination. Each individual component has some preclinical basis, but interactions between all four have not been studied together. It is not approved for human use and should be treated as highly investigational.
Reported benefits
- Supports soft-tissue and connective-tissue repair
- Studied for anti-inflammatory activity in preclinical gut and skin models
- Associated with collagen and skin-quality support
- General recovery and inflammation-related research interest
How it works
BPC-157, TB-500, and GHK-Cu contribute the tissue-repair, angiogenic, and collagen-related mechanisms described for GLOW. KPV is proposed in preclinical studies to reduce inflammatory signaling, including through modulation of NF-κB pathway activity and reduced pro-inflammatory cytokine production, independent of classical melanocortin-receptor-driven pigmentation effects. Proponents describe the four-peptide combination as broadening anti-inflammatory coverage alongside structural and dermal repair, though this has not been verified through controlled research.
Dosing ranges
| Tier | Dose | Frequency |
|---|---|---|
| Low | 350 mcg | once daily |
| Moderate | 550 mcg | once daily |
| High | 800 mcg | once daily |
Estimate your dose
Dose estimator
Educational estimate for KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV), scaled to body size. Not medical advice.
Read before using
This tool produces a rough, educational estimate by scaling commonly-published research ranges to lean body mass. It is not a prescription, medical advice, or a substitute for a licensed clinician. Most peptides use fixed dosing, not weight-based dosing. Individual needs vary. You are solely responsible for how you use this information.
Mixing & syringe units
Target dose follows the estimate above. Change it there, or edit it directly below.
Reconstitution calculator
How much water to add and how many insulin-syringe units to draw for KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV). Educational only.
Draw to this mark
11units
= 0.11 mL for a 550 mcg dose
Concentration
5,000 mcg/mL
Doses per vial
18
A U-100 syringe reads 100 units per mL. This is a reconstitution math helper only, not a prescription or dosing advice. Verify every calculation and consult a qualified healthcare provider.
Possible side effects
Stacking notes
The most complex of the commonly referenced healing blends. Given limited combined data, some researchers prefer to trial the individual components, or the simpler BPC-157/TB-500 and GLOW combinations, before using the full four-peptide blend.
Common protocols
Common questions
What is KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) used for?
KLOW adds KPV, a tripeptide fragment derived from alpha-melanocyte-stimulating hormone, to the GLOW Blend's combination of BPC-157, TB-500, and GHK-Cu. KPV is studied in preclinical models mainly for anti-inflammatory activity in gut-related and dermatological contexts, reportedly without the pigmentation effects associated with full melanocortin-receptor activation. As the newest and most complex of the commonly referenced healing blends, KLOW has the least combined research behind it, with most information originating from informal research communities rather than published studies of the four-peptide combination. Each individual component has some preclinical basis, but interactions between all four have not been studied together. It is not approved for human use and should be treated as highly investigational. Reported benefits include supports soft-tissue and connective-tissue repair, studied for anti-inflammatory activity in preclinical gut and skin models, associated with collagen and skin-quality support.
What is a typical KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) dose?
Reported ranges run 350-800 mcg. A low protocol is 350 mcg once daily, and a high protocol is 800 mcg once daily. This is reference information, not a dosing recommendation.
What is the half life of KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV)?
KPV is reported to have a short half-life on the order of minutes to about an hour in preclinical pharmacokinetic data, similar in range to GHK-Cu; combined with the longer-acting BPC-157 and TB-500, the blend's overall duration is uneven across its four components.. That is what sets the dosing frequency, and it is why the timing guidance is morning, or split am/pm.
How is KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) administered?
Subcutaneous: into fat, under the skin. Injected subcutaneously, generally into the abdomen; given the four combined actives, some research protocols recommend rotating sites and monitoring for irritation more closely than with simpler blends.
How long is a KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) cycle?
4 weeks on, followed by 4 weeks off. A more conservative cycle length than the simpler blends is often recommended given the limited combined-use data for four actives together.
What are the side effects of KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV)?
Reported side effects include injection site irritation, mild nausea, lethargy, headache (uncommon). Evidence level for this compound is emerging research.
Partner offer · $20 off
When did you last
check your blood work?
Regular blood work catches changes early. At-home collection with free pickup, 50+ biomarkers, and results in 72 hours.
- 1Order your kitTakes two minutes online, $20 off with this link.
- 2Collect at homePainless draw with free home pickup, no lab visit.
- 3Results in 72 hours50+ biomarkers with clear optimal ranges.
Partner offer · opens rythm.health
Educational use only, not medical advice. This profile is provided for research and educational purposes. KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) may be a research compound or a prescription medication; nothing here is intended to diagnose, treat, cure, or prevent any disease. Dosing figures reflect commonly-published research ranges, not a prescription. Consult a qualified healthcare provider before making any health decision. Read the full disclaimer →